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STUDIES ON THE ZINC METABOLISM IN PATIENTS 
WITH MALIGNANT TUMORS: AMOUNTS OF ZINC 
IN TUMOR TISSUE, BLOOD AND URINE. 
by 
KENJI OBAYASHI 
From the Second Surgical Division, Yamaguchi Medical Schol. 
(Director: Prof. Dr. SHUNJI TmrnoKA) 
The zinc metabolism in the patients with malignant tumors, which had been 
confirmed with surgical operations, was studied by measuring the amounts of zinc 
in the tumor tissue, in the blood (serum, red blood cells and whole blood) and in 
the urine with the dithizone method which had been modified bY VALLEE and others. 
The results were also compared with the clinical pictures and pathological findings 
in the patients. 
The amount of zinc in the malignant tumor tissue was increased markedly 
compared with that in the normal tissue from which the tumor had developed. In 
the both dried and fresh specimens from carcinoma, the amount of zinc was about 
twice that in the normal tissue. In case of sarcoma, it was 10 times as much as 
in the normal tissue. 
The relation between the zinc content and the malignancy of the tumor cells 
was investigated. The more vigorously dividing the tumor cells and the lower the 
degree of cel di首erentiation, the more amount of zinc was found in the tumor 
tissue in general. The results are shown in Table I. In addition, the water content 
of the malignant tumor tissue was larger than that of the normal tissue. 
The zinc content of the serum of the patients with malignant tumors was 
much smaller than that in the normal persons and m the non-carcinomatous 
patients. A directly proportional relationship was found between the serum zinc 
content and the hemoglobin level and the red blood cel count in the blood of the 
patients with malignant tumorぉ， asshow in Fig. 6. Thus, the higher the degree 
of anemia, the less the content of zinc in the serum. 
The diminution in the serum zinc content in the non-carcinomatous patients 
with anemia was less marked than in anemic patients with carcinoma. The degree 
of the increase in the zinc content of the red blood cel in the 11011-carcinomatous 
patients with anemia was higher than that in the carcinomatous patients with 
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anemia. The amount of zinc in the whole blood of the patients with malignant 
tumors was less than that of the normal persons, as shown in Table VI and Fig. 4. 
These facts indicate that the absolute amount of zinc in the blood is dimin-
ished in the patients with malignant tumors, even though there is a some transfer 
of zinc between the serum and the blood cels. The diminution of zinc in the 
serum of such patients is an essential change and progresses with the aggravation 
of clinical pictures of the tumor and the general physical conditions of the patients 
such as anemia. 
In order to know the degree of the liver function impairment in the patients 
with malignant tumors, the serum cholinesterase level was measured. The decrease 
in the cholinesterase level was direct!~· proportional to the decrease in the serum 
zinc content as shown in Table lV and Fig. 2. The serum albumin level and the 
serum zinc content were also proportional as well, as shown in Table IVand Fig. 3. 
It is of interest to compare these results with the already known fact that 
albumin is increased in the tumor tissue and decreased in the 日erum. Zinc in the 
serum ma~＇ be classified into two kinds, LZn, and FZn. LZn is dissociated with 
alminum oxide and said to be present mostly in albumin, while FZn is not dissoci-
ated with alminum oxide and is mainly in globulin fraction. Therefore, in the 
patients with malignant tumors, it is surmised that LZn with albumin is decreased 
markedly in the serum and increased in the tumor. Beside~.， the increase in the 
amount of spermine in the malignant tumor tissue and that in the zinc content 
were proportional as shown in Fig. 7. It is possible that zinc maγbe combined 
with this amine in the malignant tumor tissue. 
Final!~＂ the urinary excretion of zinc in the patients with malignant tumors 
was not altered markedly compared with that in the normal persons, except a mild 
decrease in the cases with markedly decreased serum zinc content (Table L¥ and 
Fig. 5). 
These results may show some facets in the zinc metabolism in the patients 
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TABLE (Il) Zinc Contents and Water Contents of Malignant Tumor Tissues. 
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TABLE (]([) Zinc Contents of Serum, Erythrocytes, Whole Blood in Normal Individual. 
Serum ! Erythrocytes i Whole Blood 
Meterr函函元l inc cont函£ I ：臨函－誌証訂正了 Z1nc・-;0i1e:凶「E百石re記百gj Zinc content 








































































































TABLE (lV) Zine Contents of Serum, Erythrocytes and Hemoglobin Lebel in Blood, 
Cholinesterase, Albumin, Globurin, Alk-phospatase in Serum of Patients with 
Malignant Tumor. 
！ 一一寸 一S竺L 恒竺roc:y
: Diagnosis l，野 I~~I <>n ~ ~ · 
(IJ ' H 竺r-1 8 I-<同ロ（ .: '"' ~ i ~ ~ ：お-Sig苦情宮古zさえ！
z 1~ 芸 ！呂れ！日g。回口同8ぶl
s. A" [50ゆ［Lingualcancer . I 0.072 
M. W.[34［合Maxillarycancer I 0.072 
H. T. [46間Thyroidalcancer I 0.064 
T. H. [23停［Mammarycancer I 0.103 
H. M. [67附Esophagealca即位 I 0.64 
K. T.J4?1♀［Gastric cancer (cardia川 0.059,
K. J. [45惜IGぉtriccancer (cardia川 0.095
S. K. [54問Gastriccancer (body) I 0.04 
T. K. [54凶Gぉtriccancer (body〕 I0.042 
U. W.[51附Gastriccancer (body) I 0.057 
S. Y. [45附G出 triccancer (body) [ 0.061 
F. F. [50同Gastriccancer (body川 0.062
S. S. [39問Gastric凶 ncer(body) I 0.063 
T. 0. [6I['C!>[Gastric cancer (body川 0.069
A. Y" [58剛Gastriccancer (body) I 0.081 
K. 0.[46問G田 triccancer (body) I 0.101 
S. S. [48恰［Gぉtriccancer (pylorus)[ 0.052 
K. S. [37問Gastriccancer (pylorus)[ 0.058 
N. U.[63同Gastriccancer (pylorus)[ 0.06 
G. W. [69恰！Rectalcancer I 0.063 
M. K.[55［♀［Uterine cancer I 0.046 
R. F. [60停［Uterinecancer I 0.0561 
M. Y.:5Ii♀［Uterine cancer I 0.064 
K. M}7問Uterinecancer / 0.075 
M. S. 63岡Uterinecancer I 0.08 
S. S. [49！合甲山ndcell sarcoma I 0.055 
I I I (h叫 face)
M. A.160冶［Fibrosarcoma 
: 1 (axilla) 
H. N. [47浮！Myelosarcoma 
I ; 1 (pelvis) 
U. M.164［♀！Polygonal cell 




















































































































































































































4.2 3.5 3.3 0.63 448 15.06 0.438 0.96 
2.8 3.8 3.2 0.72 324 12.2 13.04 0.3781 1.05 0.063 
3.9 2.4 3.6 0.42 350 8.3 13.73 0.398 0.87 0.05 
4.0 
健常人の血清亜鉛量の平均値よ り低値であるがp 著明














Fig Cl) Zinc Contents of Plasma in Patients 
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TABLE CV) Zinc Contents of Serum, Erythrocytes of Anemic Patients without 
Malignant Tumor. 
Name IAgelSex 
Serum l~~t：＿：と Hemoglo・ IErythro- I Hen 
Diagnosis Meter jZinc Meter ;Zinc bin lcytes I 
!reading!content 1readi昭 contentI g/dl I×J04 cells I % 
一一一一一一一一一 一一一（Z~！） ＿！（yperml)(Iml) (;perm!) 一ー一｜一一一一｜一一一－
K. T.119 I♀！Duodenal I 0.087 I 1.50 I 0.392 I 13.5 I 9.0 I 330 I 35.5 
ancylostomiasis I I I I 
H. K.l 52 I♀！Duodenal I 0.59 I r.20 I o.490 I 16.9 I 8.8 I zso I 31.4 
ancy lostomiasis 
s. M.I zs I合！Duodenal
I ancylostomiasis 
T. N.l 13 I合！Hemorrhage
K. O.I 71 I合！Duodenalulcer 
K. K.I 46 I合！Duodenalulcer 
Y. U.J 35 I合！Chronicnephritis 












14.0 8.5 310 30.2 
20.0 5.6 195 16.5 
17.4 6.5 325 26.1 
12.9 8.1 215 30.3 
9.97 7.4 175 26.0 









Fig r 2 I Relation between Serum Zinc Content 






















-,-;- Normal range 
Fig・ (3) Relations between Serum Zinc Content 
and Serum Albumin, Globurin Lebel of 
Patients with Malignant Tumor. 
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TABLE ~VI ) Zine Contents of Whole Bloods in Patients with Malignant Tumor. 
Name Age Sex Dia宮nosis 
M. W. J 34 合 Maxillarycancer 
T. H. 23 ♀ Mammary cancer 
K. I. 45 合 Gastriccancer (cardia) 
K. 0. 46 早 Gastriccancer (body) 
T. K. 54 合 Gastriccancer (body) 
Y. F. 50 ♀ Gastric cancer (body) 
N. U. 63 ♀ Gastric cancer (pylorus> 
R. F. 60 ♀℃tcrinc cancer 
M. S. 63 ♀ Uterine cancer 
M. Y. 51 ♀ Uterine cancer 
K. M. 47 ♀ l Uterine cancer 
s. M. I 49 合 Roundcell sarcoma 
M.A. 60 合 Fibro sarcoma 
H. N.; 47 I ♀ i My山町oma
I yャー
Meぬrreading (lml〕IZinc content (yper ml) 
I o.1s1 I s.17 
I o.山 I -1.84 
0.158 : 5.40 





















Fig・ 14' Zinc Content of Whole Blood in Patients 多型細胞肉腫の各l例）に就いて24時間尿中に排出し
with Malignant Tumor. た亜鉛量ーをilW'，ヒしたが，（表医）図（5）に示す如く 0.286
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TA.8LE (V[) Zinc Contents of Serum, Erythrocytes in non-Sarcinomatous, 
non-Anemic Patients. 
山 IAgolSex！…s
T. E. I 27 I♀ I Chronic mastopathy 
M. K. I 41 I♀ I Chronic mastopathy 
K. F. I 23 I合 IGastric ulcer 
K. K. I 18 I♀ I Coecum mobil巴
T. T. I 56 I合 lInguinal hernia 
A.H. I 55 I♀ I Femoral hernia 
M. M. I 31 1合 IHemorrhoids 
H. N. I 23 I合 lHemorrhoids 
s. K. I 27 I合 IHemorrhoids 
M. M. I 20 I合 IAcute appendicitis 
K. T. I 24 I合 iPerianal abscess 
Serum Erythrocytes与
Meter • Zinc co画面五「 i辰五了一 • Zinc content 
read~堕2rnl l__ (yper_!!_!) _ :rea~ini; lm_l_ ' （ヨ竺堕l) 一
0.084 I 1.45 I 0.324 I 11.l 
0.085 I I.46 I. 0.304 I 10.5 
0.088 ! I.52 I 0.262 I 9.0 
0.085 I 1.46 I o.304 I 10.5 
0.084 I 1.45 I o.372 I 12.8 
0.092 I 1.6 I 0.342 I 1.8 
0.092 I 1.6 I o.380 I ・13.2 ・ ・ 
0.122 I 2.1 I 0.292 I 10.2 
0.087 I 1.5 I o.336 I 11.6 
0.090 I 1.55 I 0.278 I ,9.55 
0.094 I 1.63 I 0.364 I 12.5 








Urine volume ml 











I Zinc content 
Meter reading(lOml〕｜ 中〓川 n；一一一…h! Zinc per.（伽t)I J.O聞記；5eraay 
0.215 I 7.36 I 0.934 
0.201 I 6.90 I J.035 
0.142 I 4.87 I 0.536 
0.126 I 4.35 I 0.827 
0.201 I 6.90 I o.690 
0.182 I 6.22 I 1.123 
TABLE （庇） Zinc Contents of the 24-Hour Urine Specimen of Patients with Malignant Tumor. 
竺ご；平： Urine VolumeMeter reading Zinc content Diag・nosis (24 hours〕｜ (!Om！〕 ]zinc per伽 ly ¥To凶 Zincper day (mg〕
M. Y. 51 880 0.238 8.18 0.720 
K. M. 47 ♀ Uterine cancer llOO 0.258 8.91 0.980 
S. K. 54 ♀ Gastric cancer 680 0.124 -1.:!6 0.280 
T. K. 54 合 IGastric cancer 750 0.137 4.69 0.352 
Y. F. 50 ♀ Gastric oancer 1000 0.134 4.60 0.460 
K. 0. 46 ♀I Gastr…cer 640 0.256 8.82 0.563 
A. Y. 58 合 Gastriccancer 1760 0.114 3.93 0.692 
N. U. 63 ♀l Gastric cancer 1600 0.198 6.83 0.092 
S. M. 49 合 l Roundcell sarcoma 1100 0.176 5.86 0.645 
U. M.164 f 引Polygonalcel sarcomai 900 0.126 4.40 0.400 
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Fif (5) Zinc Contents 0£ 24-Hour Urine 
Specimen of Patients with Malignant 
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は41.l が邑／kg乾量p 牟礼23l!00.24mg/kg乾量であっ るらしい亜鉛が何放に3悪性彊疹組織には抑制的に働
























Fig (6) Relation between Serum Zinc Content 
and Hemo広lobin Lebel in Blood of 
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では貧血著明な癌患者10例の血清亜鉛量の平均は 1.05 は非癌貧血患者の血清亜鉛量よ りはるかに低値である
y/mlであって，健常人血清の平均亜鉛含量1.58)/mlは にもかかわらず，癌貧血患者の赤血球亜鉛量には非癌















































血清中Zn°＇の28°，はアルブミンに， 21.21°,;a夫々 :x1-, 




ルプミンp ~lー グロプリ ン中の斑鉛は大部分 LZn であ
って， "1> :x, －ゲロプリン中の亜鉛は殆んど FZn46lで






















Fig・ (7> Relation between Amount of Spermine 
and Zinc Content in Malignant Tumor 
Tissue. 
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